Progyny, Inc. (PGNY)

Market Cap	3.15B
Revenue (ttm)	1.09B
Net Income (ttm)	62.04M
Shares Out	96.50M
EPS (ttm)	0.62
PE Ratio	52.03
Forward PE	45.56
Dividend	n/a
Ex-Dividend Date	n/a

Volume	759,132
Open	32.30
Previous Close	32.40
Day's Range	32.00 - 32.61
52-Week Range	29.44 - 44.95
Beta	1.48
Analysts	Strong Buy
Price Target	48.71 (+49.42%)
Earnings Date	May 6, 2024

About PGNY

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various servic...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Oct 25, 2019
• Employees: 566
• Stock Exchange: NASDAQ
• Ticker Symbol: PGNY

Financial Performance

In 2023, Progyny's revenue was $1.09 billion, an increase of 38.34% compared to the previous year's $786.91 million. Earnings were $62.04 million, an increase of 104.35%.

Analyst Forecast

According to 7 analysts, the average rating for PGNY stock is "Strong Buy." The 12-month stock price forecast is $48.71, which is an increase of 49.42% from the latest price.

Price Target

$48.71

(49.42% upside)

Analyst Consensus: Strong Buy